Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

FLT3-ITD Enhances Proliferation and Survival of AML Cells through Activation of RSK1 to Upregulate the mTORC1/eIF4F Pathway Cooperatively with PIM or PI3K and to Inhibit Bad and Bim

Ayako Nogami, MD PhD BPharm, Daisuke Watanabe, MD, Keigo Okada, MD, PhD, Hiroki Akiyama, MD, PhD, Yoshihiro Umezawa, MD, PhD, Toshikage Nagao, MD, PhD, Shuji Tohda, MD, PhD, Osamu Miura, MD, PhD

Blood (2019) 134 (Supplement_1): 1425.

https://doi.org/10.1182/blood-2019-123183

Published: 2019

Journal Articles

Mechanisms of Suppressive Effects of MYD88 Inhibitors on the Growth of Lymphoma and Leukemia Cells

Erika Shiratori, Mai Itoh, PhD, Mika Ohtaka, Shohei Nogami, Shuji Tohda, MD PhD

Blood (2016) 128 (22): 2773.

https://doi.org/10.1182/blood.V128.22.2773.2773

Published: 2016

Journal Articles

Effects of GLI1 and CTNNB1 Knockdown on Notch Signaling and Proliferation of AML and T-ALL Cell Lines

Yuki Okuhashi, PhD, Yusuke Takahashi, Mika Ohtaka, Erika Shiratori, Shijyun O, Mai Itoh, PhD, Shuji Tohda, MD PhD

Blood (2014) 124 (21): 1042.

https://doi.org/10.1182/blood.V124.21.1042.1042

Published: 2014

Journal Articles

Effects of Hypoxia on HIF, Notch, Akt, and NF-κB Signaling in Leukemia Cell Lines

Mai Itoh, PhD, Yusuke Takahashi, Yuki Okuhashi, Shuji Tohda, MD, PhD

Blood (2013) 122 (21): 3874.

https://doi.org/10.1182/blood.V122.21.3874.3874

Published: 2013

Journal Articles

Effects of NOTCH Knockdown on the Proliferation and mTOR Signaling of T-ALL and AML Cell Lines

Yuki Okuhashi, Mai Itoh, PhD, Nobuo Nara, MD, PhD, Shuji Tohda, MD, PhD

Blood (2013) 122 (21): 1396.

https://doi.org/10.1182/blood.V122.21.1396.1396

Published: 2013

Journal Articles

Development of a Bruton's Tyrosine Kinase (Btk) Inhibitor, ONO-WG-307: Efficacy in ABC-DLBCL Xenograft Model – Potential Treatment for B-Cell Malignancies,

Ryohei Kozaki, Toshio Yoshizawa, Shuji Tohda, MD, PhD, Tomoko Yasuhiro, Shingo Hotta, Yuko Ariza, Yoshiko Ueda, Masami Narita, Kazuhito Kawabata

Blood (2011) 118 (21): 3731.

https://doi.org/10.1182/blood.V118.21.3731.3731

Published: 2011

NARROW

FLT3-ITD Enhances Proliferation and Survival of AML Cells through Activation of RSK1 to Upregulate the mTORC1/eIF4F Pathway Cooperatively with PIM or PI3K and to Inhibit Bad and Bim

Mechanisms of Suppressive Effects of MYD88 Inhibitors on the Growth of Lymphoma and Leukemia Cells

Effects of GLI1 and CTNNB1 Knockdown on Notch Signaling and Proliferation of AML and T-ALL Cell Lines

Effects of Hypoxia on HIF, Notch, Akt, and NF-κB Signaling in Leukemia Cell Lines

Effects of NOTCH Knockdown on the Proliferation and mTOR Signaling of T-ALL and AML Cell Lines

Development of a Bruton's Tyrosine Kinase (Btk) Inhibitor, ONO-WG-307: Efficacy in ABC-DLBCL Xenograft Model – Potential Treatment for B-Cell Malignancies,

Email alerts

ASH Publications

American Society of Hematology

FLT3-ITD Enhances Proliferation and Survival of AML Cells through Activation of RSK1 to Upregulate the mTORC1/eIF4F Pathway Cooperatively with PIM or PI3K and to Inhibit Bad and Bim

Mechanisms of Suppressive Effects of MYD88 Inhibitors on the Growth of Lymphoma and Leukemia Cells

Effects of GLI1 and CTNNB1 Knockdown on Notch Signaling and Proliferation of AML and T-ALL Cell Lines

Effects of Hypoxia on HIF, Notch, Akt, and NF-κB Signaling in Leukemia Cell Lines

Effects of NOTCH Knockdown on the Proliferation and mTOR Signaling of T-ALL and AML Cell Lines

Development of a Bruton's Tyrosine Kinase (Btk) Inhibitor, ONO-WG-307: Efficacy in ABC-DLBCL Xenograft Model – Potential Treatment for B-Cell Malignancies,

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only